H+/K+ ATPase β inhibitors belong to a class of chemical compounds that selectively target and inhibit the β subunit of the H+/K+ ATPase enzyme. The H+/K+ ATPase, also known as the gastric proton pump, is a key enzyme involved in the regulation of gastric acid secretion in the stomach lining. The β subunit of this enzyme plays a crucial role in facilitating the proton-potassium exchange necessary for acid production. By specifically inhibiting the β subunit, H+/K+ ATPase β inhibitors disrupt the normal functioning of the enzyme, leading to a reduction in the secretion of gastric acid.
Chemically, these inhibitors are designed to interact with the active site of the H+/K+ ATPase β subunit, disrupting its enzymatic activity. The selectivity for the β subunit distinguishes them from other proton pump inhibitors, making them a targeted approach for modulating gastric acid production. Understanding the molecular structure and interactions of these inhibitors is crucial for optimizing their pharmacological properties and enhancing their specificity. Researchers focus on refining the chemical structures of H+/K+ ATPase β inhibitors to improve their potency, bioavailability, and selectivity, paving the way for potential applications in addressing conditions associated with gastric acid dysregulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
3184-13-2 reduces secretion of gastric acid by inhibiting the ion pump H+/K+ ATPase in gastric parietal cells. | ||||||
Pantoprazole | 102625-70-7 | sc-204830 sc-204830A | 100 mg 500 mg | $87.00 $250.00 | 2 | |
Pantoprazole binds to the H+/K+ exchanging ATPase in gastric parietal cells, resulting in blockage of the final step of gastric acid production. | ||||||
Rabeprazole | 117976-89-3 | sc-204872 sc-204872A | 10 mg 25 mg | $342.00 $608.00 | 2 | |
Rabeprazole inhibits the H+/K+ ATPase enzyme, which is responsible for secreting acid in the stomach, thereby reducing gastric acidity. | ||||||
Lansoprazole | 103577-45-3 | sc-203101 sc-203101A | 500 mg 1 g | $58.00 $173.00 | 6 | |
Lansoprazole inhibits the H+/K+ ATPase, thus reducing gastric acid secretion and concentration. | ||||||
(R)-Lansoprazole | 138530-94-6 | sc-208242 | 1 mg | $240.00 | 2 | |
(R)-Lansoprazole is an enantiomer of lansoprazole that inhibits gastric acid secretion by inhibiting the H+/K+ ATPase at the secretory surface of the gastric parietal cell. | ||||||
SCH 28080 | 76081-98-6 | sc-204269 sc-204269A | 10 mg 50 mg | $275.00 $969.00 | 1 | |
SCH 28080 is a direct, reversible antagonist of the gastric H+/K+ ATPase, reducing acid secretion in the stomach. | ||||||